3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Promyelocytic, Acute
1
Graft vs Host Disease
1
Interventions
Arsenic Trioxide
21
Tretinoin
20
Cytarabine
12
Cyclophosphamide
11
Busulfan
10
Methotrexate
9
Idarubicin
9
Filgrastim
8
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
6
Tacrolimus
5
Gemtuzumab
5
Etoposide
5
Radiotherapy
4
Clofarabine
4
Antilymphocyte Serum
4
Topotecan
3
Mycophenolic Acid
3
Mitoxantrone
3
Mercaptopurine
3
Daunorubicin
3
venetoclax
2
lintuzumab
2
Whole-Body Irradiation
2
Thiotepa
2
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Cyclosporins
2
Cyclosporine
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Promyelocytic, Acute
×
Leukocyte Count
×
Clear all
NCT04562818
2020-09-24
Mexico APL
Instituto Nacional de Cancerologia de Mexico
Completed
360 enrolled